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MR Imaging Findings of Ovarian
Cystadenofibroma and
Cystadenocarcinofibroma: Clues for the
Differential Diagnosis
Objective: We wanted to assess the MR imaging findings of ovarian cystade-
nofibroma and cystadenocarcinofibroma, and we wanted to find clues for making
the differential diagnosis between them. 
Materials and Methods: The MR images of 12 pathologically proven cystade-
nofibromas and two cystadenocarcinofibromas were reviewed, with a focus on
the internal architecture, signal intensity and enhancement. 
Results: All the tumors appeared as multilocular cysts, except for a single
unilocular cystic mass and a single solid mass. The previously reported charac-
teristic MR findings of cystadenofibroma (a multilocular cystic mass with a T2-
dark-signal-intensity solid component containing small cystic locules) were found
in only 43% of the tumors (6/14). Diffuse or partial thickening of the cyst wall with
T2-dark signal intensity without a definite solid component was as common as
the previous reported findings (6/14). Two cystadenocarcinofibromas showed
more prominent solid portions with higher T2-signal intensities and stronger
enhancement than did the cystadenofibromas.
Conclusion: Diffuse or partial thickening of the cyst wall with dark-signal-inten-
sity in multilocular cystic masses may suggest ovarian cystadenofibroma, and
this type of appearance may be as common as the previously reported character-
istic appearance. A prominent solid component with a higher T2-signal intensity
and strong enhancement are the typical findings of cystadenocarcinofibroma. 
varian cystadenofibroma (CAF) is a benign tumor that contains both
epithelial and stromal components. It is rarely malignant, but it often
mimics malignancy on imaging, and this mainly due to a well-enhancing
solid component in the cystic mass (1 4). Outwater et al. reported that this solid
component shows low signal intensity similar to skeletal muscle on the T2-weighted
MR images because of the presence of fibrous tissue (5). Takeuchi et al. also reported
that small or tiny cystic locules within this solid component are the characteristic
findings of CAF, and they correspond to a black sponge-like appearance on the T2-
weighted image (6). However, these findings are not specific and they may not be
evident on all cases. We have encountered several cases of CAF that show different
MR imaging findings from the previous characteristic findings.
Cystadenocarcinofibroma (CACF) is the malignant counterpart of the CAF. CACF is
very rare and there is no report of the MR imaging findings of this tumor in the litera-
tures. We have recently encountered two cases of CACF. 
The purpose of this study was to assess the MR imaging findings of ovarian CAF and
CACF, and we wanted to find clues for making the differential diagnosis between
them.
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OMATERIALS AND METHODS
Twelve pathologically confirmed cases of CAF in 11
patients and two cases of CACF were included in this
study. The ages of the patients ranged from 24 to 62 years
(mean age: 48 years).
All the MR imagings were performed using 1.5 or 3 Tesla
(T) units. The patients were scanned with a variety of fast
spin-echo (or turbo spine echo) pulse sequences that were
optimized for the MR imaging unit and for the patients’
body parameters. The routine sequence consisted of the
sagittal and axial T2-weighted images, and these were
followed by the axial T1-weighted images. The fat
saturated and contrast enhanced T1-weighted images were
also obtained. 
Three radiologists, who were unaware of the histopatho-
logic diagnoses, reviewed the MR images. The following
findings were analyzed: 1) the morphology, size, location
and internal architecture of the tumor, 2) the characteris-
tics of the signal intensity, and 3) the contrast enhancement
pattern of the tumor. The signal intensities of the internal
structures on the T2-weighted sequences were classified as
low (similar to muscle), intermediate (similar to
myometrium), or high (similar to simple fluid). The degrees
of contrast enhancement on the MR images were assessed
and then compared with that of the normal uterine
myometrium, and they were classified as none, mild (less
than myometrium), moderate (equal to myometrium), or
marked (greater than myometrium). The findings were
determined by a consensus of the three experienced radiol-
ogists. 
RESULTS
The results are summarized in Table 1. Among the 13
patients, 12 patients had unilateral lesions and one had
bilateral lesions. The tumor sizes ranged from 1.9 to 23.0
cm (mean; 7.4 cm) at the longest diameter. The margins of
all the tumors were well defined with smooth borders. The
histologic types were serous in eight, mucinous in five, and
endometrioid type in one.
All the tumors appeared as multilocular cysts, except for
a single unilocular cystic mass and a single solid mass. The
previously reported characteristic MR findings of CAF (a
multilocular cystic mass with a T2-dark-signal-intensity and
a solid component containing small cystic locules) were
found for only 43% of the tumors (6/14) (Figs. 1, 2).
Diffuse or partial thickening of the cyst wall with T2-dark
signal intensity and without a definite solid component
were the findings like the previous findings (6/14) (Figs. 3,
4). Circumferential wall thickening and partial wall
thickening were visible not only along the frequency
encoding direction, but also along the phase encoding
direction on the MR images, which means this dark-wall-
thickening was not caused by a chemical shift artifact.
Two CACFs had a markedly enhancing solid component
that showed intermediate signal intensity on the T2-
weighted images. The signal intensities of the solid portions
on the T2-weighted images were higher than those of their
benign counterparts (Figs. 5, 6). However, there was no
significant difference in the tumor size and margins
between the CAF and CACF. Lymphatic metastasis or
ascites was not evident in the CACF.
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Table 1. MR Imaging and the Pathologic Features of 14 Tumors
No Age Size(cm) Pathology Internal Structure
Solid Component Dark Signal 
T2 Signal Cystic Locules Enhancement Intensity Wall
1 43 6.2 Malignant Mainly  soild Intermediate + Marked
2 62 7.5 Malignant Intermediate + Marked
3 54 8.5 Benign Low + Marked
4 42 9.2 Benign Multilocular cyst Low + Mild
5 48 8.0 Benign with solid component Low + Mild
6 56 15.0 Benign Low + Mild
7 24 23.0 Benign Low + Mild
8 61 5.5 Benign +
9 58 2.7 Benign +
10 58 6.0 Benign Multilocular cyst +
11 55 5.5 Benign with irregular wall component +
12 36 3.5 Benign +
13 61 11.0 Benign +
14 25 1.9 Benign Unilocular cystMRI Findings of Ovarian Cystadenofibroma and Cystadenocarcinofibroma
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AB
Fig. 1. A 42-year-old woman with a mucinous cystadenofibroma. 
The T1- (A) and T2-weighted (B) MR images show a multilocular
cystic mass with a solid component (arrows) in the right ovary. The
solid component (black arrowheads) shows low signal intensity and
it contains multiple, small cystic locules (white arrowheads).
C. The contrast-enhanced T1-weighted sagittal MR image with fat-
suppression shows mild enhancement in the solid component
(arrowheads) within mass (arrows).
C
Fig. 2. A 24-year-old woman with a
mucinous cystadenofibroma.
A. The T2-weighted sagittal MR image
shows a huge multilocular cystic mass
(arrows) with a solid component in the
left ovary. The solid component with low
signal intensity contains small cystic
locules (arrowheads).
B. The contrast-enhanced T1-weighted
sagittal MR image with fat-suppression
shows mild enhancement in the solid
component (arrowheads) within mass
(arrows). 
ABDISCUSSION
Ovarian CAF is a composite neoplasm that contains both
benign epithelium and stroma. Adenofibromas of the
ovary are tumors with neoplastic glandular elements and a
predominant, benign stroma. When large cystic spaces are
present within the glandular elements, then the tumor is
designated as CAF. CAF belongs to the surface epithelial
tumors, and these contain various amounts of fibrous
stroma in all the subtypes. The subtypes of this tumor are
the benign, proliferating and malignant tumors that are
categorized by the cytologic features of the glandular
component (1, 2). Although the real incidence of CAF is
uncertain, some investigators believe that it is more
common than has been reported (4).
The MR imaging findings of CAF have not been widely
investigated (5 7). The previously described MR findings
(a multilocular cystic mass with a T2-dark-signal-intensity
solid component containing small cystic locules) were
observed in 43% of our cases, but these were not the
predominant findings of CAF in our study. Our study
revealed that multilocular ovarian cysts with diffusely or
partially thickened, dark-signal-intensity walls on the T2-
weighted images were the other findings that occurred in
our study at with same frequency as the previous findings.
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Fig. 4. A 58-year-old woman with a serous cystadenofibroma.
The T2-weighted MR images in the axial (A) and sagittal (B) planes show a bilocular cystic mass (arrows) surrounded by a partly-
thickened wall of dark-signal-intensity (small arrows) in the left ovary. Note the presence of focal nodular thickening (arrowheads).
AB
Fig. 3. A 58-year-old woman with a serous cystadenofibroma.
The T1- (A) and T2-weighted (B) MR images show a multilocular cystic mass in the right adnexal region (arrows). The wall of the mass
was irregularly and partially thickened, and it appeared as dark signal intensity on this T2-weighted image. 
ABThis dark-signal-intensity thickening may represent a dense
fibrous component within the wall, although no precise
correlation with the pathologic finding was made. 
Other ovarian tumors may demonstrate dark-signal-
intensity rims on the T2-weighted images. Endometriotic
cysts may contain a peripheral rim of low-signal-intensity,
and this represents hemosiderin or a fibrous capsule (8).
The ovarian masses with fibrous components, including
fibroma, fibrothecoma and Brenner tumor, are benign
tumors with a predominantly solid component, and they
demonstrate low signal intensity on the T2-weighted
images (9 12). Metastases with a high fibrous component
(particularly from the gastrointestinal tract) often show
hypointense areas on the T2-weighted images with strong
enhancement (13). Struma ovarii may have solid
components, multilocular cystic components and multilob-
ulated surfaces. Cystic locules contain viscid gelatinous
materials and they show as low signal intensity on the T2-
weighted images with no contrast enhancement. A charac-
teristic clinical setting (associated hyperthyroidism) and
preoperative scintigraphy may be useful for differentiating
struma ovarii from the other ovarian tumors (14). 
In general, the likelihood of malignancy increases with
an increasing solid tissue portion and thicker septa.
Although contrast enhancement usually increases the
accuracy of differentiating benign from malignant lesions,
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Fig. 5. A 62-year-old woman with an endometrioid cystadenocarcinofibroma.
A. The T2-weighted MR image in the sagittal plane shows a multilocular cystic mass (arrows) with a solid component (black arrowheads)
in the left ovary. Partial thickening with dark-signal-intensity was noted in the superior part of the wall (white arrowheads). The solid
component shows relatively higher signal intensity compared with the benign counterpart in Figure 1 and 2. 
B. The contrast-enhanced T1-weighted sagittal MR image with fat-suppression shows strong enhancement in the mass (arrows).
AB
Fig. 6. A 43-year-old woman with serous cystadenocarcinofibroma.
A. The T2-weighted MR image shows a mainly solid mass (arrows) in the left ovary. The mass contained multiple, small cystic locules
(arrowheads) and it was of intermediate signal intensity.
B. The contrast-enhanced T1-weighted MR image shows strong enhancement in the solid component (arrows).
ABits usefulness may be limited for some types of tumors
(15). In our study, the malignant tumors (CACF) had a
greater sized solid portion with strong enhancement and
higher signal intensity compared with the benign tumors
(CAF).
Our study has several limitations. First, the small
numbers of cases might not accurately reflect the full
imaging spectrum of these tumors. Second, we included
only the patients who had undergone MR examinations,
which could result in a selection bias. Finally, precise
pathologic correlation with the imaging findings was not
performed.
In conclusion, diffuse or partial thickening of the cystic
wall with a T2-dark-signal-intensity in multilocular cystic
masses is another suggestive MR finding of ovarian CAF,
as well as the previously reported characteristic findings. A
prominent solid component with a higher T2-signal
intensity and strong enhancement may represent its
malignant counterpart. 
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